Phreesia, Inc. (PHR)
NYSE: PHR · Real-Time Price · USD
25.16
+1.32 (5.54%)
Dec 20, 2024, 4:00 PM EST - Market closed
Phreesia Market Cap
Phreesia has a market cap or net worth of $1.46 billion as of December 20, 2024. Its market cap has increased by 47.09% in one year.
Market Cap
1.46B
Enterprise Value
1.40B
1-Year Change
47.09%
Ranking
Category
Stock Price
$25.16
Market Cap Chart
Since July 18, 2019, Phreesia's market cap has increased from $882.45M to $1.46B, an increase of 65.72%. That is a compound annual growth rate of 9.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 1.46B | 13.55% |
| Dec 29, 2023 | 1.29B | -24.54% |
| Dec 30, 2022 | 1.71B | -20.04% |
| Dec 31, 2021 | 2.13B | -10.92% |
| Dec 31, 2020 | 2.40B | 150.66% |
| Dec 31, 2019 | 955.98M | 8.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunocore Holdings | 1.42B |
| Nurix Therapeutics | 1.42B |
| Arcus Biosciences | 1.41B |
| Schrödinger | 1.41B |
| Novavax | 1.39B |
| U.S. Physical Therapy | 1.38B |
| Maravai LifeSciences Holdings | 1.37B |
| Spyre Therapeutics | 1.36B |